Pezzati 2000.

Methods	Blinding of randomisation: no Blinding of intervention: can't tell but probably impossible Complete follow‐up: yes Blinding of outcome measurement: can't tell
Participants	Healthy, premature infants <37 weeks GA. Infants with congenital malformations, birth asphyxia, respiratory distress, renal or gastrointestinal pathologies, patent ductus arteriosus, hypo‐ or hypertension, anaemia and polycythaemia excluded. Haemolysis permitted. Qualifying SBR >171. Fibreoptic n=20, conventional n=19.
Interventions	Fibreoptic: BiliBlanket. Conventional: Drager blue light.
Outcomes	Duration of phototherapy. Use of exchange transfusion. Absolute SBR at baseline, 24 hrs and at end of phototherapy.
Notes	Further data awaited
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	High risk	C ‐ Inadequate